124 related articles for article (PubMed ID: 9846970)
1. Selection of potentially metastatic subpopulations expressing c-erbB-2 from breast cancer tissue by use of an extravasation model.
Roetger A; Merschjann A; Dittmar T; Jackisch C; Barnekow A; Brandt B
Am J Pathol; 1998 Dec; 153(6):1797-806. PubMed ID: 9846970
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities.
Tan M; Yao J; Yu D
Cancer Res; 1997 Mar; 57(6):1199-205. PubMed ID: 9067293
[TBL] [Abstract][Full Text] [Related]
3. Heregulin and agonistic anti-p185(c-erbB2) antibodies inhibit proliferation but increase invasiveness of breast cancer cells that overexpress p185(c-erbB2): increased invasiveness may contribute to poor prognosis.
Xu FJ; Stack S; Boyer C; O'Briant K; Whitaker R; Mills GB; Yu YH; Bast RC
Clin Cancer Res; 1997 Sep; 3(9):1629-34. PubMed ID: 9815853
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of c-erbB-2/neu in breast cancer cells confers increased resistance to Taxol via mdr-1-independent mechanisms.
Yu D; Liu B; Tan M; Li J; Wang SS; Hung MC
Oncogene; 1996 Sep; 13(6):1359-65. PubMed ID: 8808711
[TBL] [Abstract][Full Text] [Related]
5. SPARC/osteonectin induces matrix metalloproteinase 2 activation in human breast cancer cell lines.
Gilles C; Bassuk JA; Pulyaeva H; Sage EH; Foidart JM; Thompson EW
Cancer Res; 1998 Dec; 58(23):5529-36. PubMed ID: 9850090
[TBL] [Abstract][Full Text] [Related]
6. An intracellular anti-erbB-2 single-chain antibody is specifically cytotoxic to human breast carcinoma cells overexpressing erbB-2.
Wright M; Grim J; Deshane J; Kim M; Strong TV; Siegal GP; Curiel DT
Gene Ther; 1997 Apr; 4(4):317-22. PubMed ID: 9176517
[TBL] [Abstract][Full Text] [Related]
7. Characterizing the HER2/neu status and metastatic potential of breast cancer stem/progenitor cells.
Pommier SJ; Quan GG; Christante D; Muller P; Newell AE; Olson SB; Diggs B; Muldoon L; Neuwelt E; Pommier RF
Ann Surg Oncol; 2010 Feb; 17(2):613-23. PubMed ID: 19838757
[TBL] [Abstract][Full Text] [Related]
8. Aberrant expression of integrin and erbB subunits in breast cancer cell lines.
Shimizu H; Koyama N; Asada M; Yoshimatsu K
Int J Oncol; 2002 Nov; 21(5):1073-9. PubMed ID: 12370757
[TBL] [Abstract][Full Text] [Related]
9. Induction of apoptosis and inhibition of c-erbB-2 in breast cancer cells by flavopiridol.
Li Y; Bhuiyan M; Alhasan S; Senderowicz AM; Sarkar FH
Clin Cancer Res; 2000 Jan; 6(1):223-9. PubMed ID: 10656453
[TBL] [Abstract][Full Text] [Related]
10. A role for endothelial-derived matrix metalloproteinase-2 in breast cancer cell transmigration across the endothelial-basement membrane barrier.
Kargozaran H; Yuan SY; Breslin JW; Watson KD; Gaudreault N; Breen A; Wu MH
Clin Exp Metastasis; 2007; 24(7):495-502. PubMed ID: 17653824
[TBL] [Abstract][Full Text] [Related]
11. Experimental co-expression of vimentin and keratin intermediate filaments in human breast cancer cells results in phenotypic interconversion and increased invasive behavior.
Hendrix MJ; Seftor EA; Seftor RE; Trevor KT
Am J Pathol; 1997 Feb; 150(2):483-95. PubMed ID: 9033265
[TBL] [Abstract][Full Text] [Related]
12. Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma.
Gilles C; Polette M; Seiki M; Birembaut P; Thompson EW
Lab Invest; 1997 May; 76(5):651-60. PubMed ID: 9166284
[TBL] [Abstract][Full Text] [Related]
13. Suppression of distant pulmonary metastasis of MDA-MB 435 human breast carcinoma established in mammary fat pads of nude mice by retroviral-mediated TIMP-2 gene transfer.
Lee YK; So IS; Lee SC; Lee JH; Lee CW; Kim WM; Park MK; Lee ST; Park DY; Shin DY; Park CU; Kim YS
J Gene Med; 2005 Feb; 7(2):145-57. PubMed ID: 15546163
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinases (MMPs) in breast cancer cell lines of different tumorigenicity.
Bachmeier BE; Nerlich AG; Lichtinghagen R; Sommerhoff CP
Anticancer Res; 2001; 21(6A):3821-8. PubMed ID: 11911253
[TBL] [Abstract][Full Text] [Related]
15. Tumor cell invasion through matrigel is regulated by activated matrix metalloproteinase-2.
Deryugina EI; Luo GX; Reisfeld RA; Bourdon MA; Strongin A
Anticancer Res; 1997; 17(5A):3201-10. PubMed ID: 9413149
[TBL] [Abstract][Full Text] [Related]
16. HMG-I(Y) recognizes base-unpairing regions of matrix attachment sequences and its increased expression is directly linked to metastatic breast cancer phenotype.
Liu WM; Guerra-Vladusic FK; Kurakata S; Lupu R; Kohwi-Shigematsu T
Cancer Res; 1999 Nov; 59(22):5695-703. PubMed ID: 10582687
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinases and metastatic cancer.
Cockett MI; Murphy G; Birch ML; O'Connell JP; Crabbe T; Millican AT; Hart IR; Docherty AJ
Biochem Soc Symp; 1998; 63():295-313. PubMed ID: 9513731
[TBL] [Abstract][Full Text] [Related]
18. The alpha 3 beta 1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (MMP-9) activity.
Morini M; Mottolese M; Ferrari N; Ghiorzo F; Buglioni S; Mortarini R; Noonan DM; Natali PG; Albini A
Int J Cancer; 2000 Aug; 87(3):336-42. PubMed ID: 10897037
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer.
Tang CK; Gong XQ; Moscatello DK; Wong AJ; Lippman ME
Cancer Res; 2000 Jun; 60(11):3081-7. PubMed ID: 10850460
[TBL] [Abstract][Full Text] [Related]
20. Increased invasive potential and up-regulation of MMP-2 in MDA-MB-231 breast cancer cells expressing the beta3 integrin subunit.
Baum O; Hlushchuk R; Forster A; Greiner R; Clézardin P; Zhao Y; Djonov V; Gruber G
Int J Oncol; 2007 Feb; 30(2):325-32. PubMed ID: 17203213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
